Experimental drug tested for painful skin blistering disease
NCT ID NCT02226146
Summary
This small, early-stage study tested an experimental drug called bertilimumab in 11 older adults newly diagnosed with moderate to severe bullous pemphigoid, a condition that causes large, itchy skin blisters. The main goals were to check the drug's safety and see if it could reduce blistering and itching while helping patients lower their steroid medication doses. Researchers measured skin symptoms, quality of life, and how well patients could taper off prednisone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEMPHIGOID, BULLOUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Iowa City, Iowa, United States
-
Research Site
Buffalo, New York, United States
-
Research Site
New York, New York, United States
-
Research Site
Durham, North Carolina, United States
-
Research Site
Cleveland, Ohio, 10900, United States
-
Research Site
Salt Lake City, Utah, United States
-
Research Site
Ramat Gan, 5262100, Israel
-
Research Site
Tel Aviv, 64239, Israel
Conditions
Explore the condition pages connected to this study.